Rupérez, María
González, Raquel
Mombo-Ngoma, Ghyslain
Kabanywanyi, Abdunoor M.
Sevene, Esperança
Ouédraogo, Smaïla
Kakolwa, Mwaka A.
Vala, Anifa
Accrombessi, Manfred
Briand, Valérie
Aponte, John J.
Manego Zoleko, Rella
Adegnika, Ayôla A.
Cot, Michel
Kremsner, Peter G.
Massougbodji, Achille
Abdulla, Salim
Ramharter, Michael
Macete, Eusébio
Menéndez, Clara
Clinical trials referenced in this document:
Documents that mention this clinical trial
Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Negative Women: A Multicentre Randomized Controlled Trial
https://doi.org/10.1371/journal.pmed.1001733
Comparison of growth models to describe growth from birth to 6 years in a Beninese cohort of children with repeated measurements
https://doi.org/10.1136/bmjopen-2019-035785
Young adolescent girls are at high risk for adverse pregnancy outcomes in sub-Saharan Africa: an observational multicountry study
https://doi.org/10.1136/bmjopen-2016-011783
Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Infected Women Receiving Cotrimoxazole Prophylaxis: A Multicenter Randomized Placebo-Controlled Trial
https://doi.org/10.1371/journal.pmed.1001735
Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study
https://doi.org/10.1371/journal.pmed.1001964